KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Realty Trust (HR) Shares Outstanding (Diluted Average) (2016 - 2025)

Healthcare Realty Trust (HR) has 16 years of Shares Outstanding (Diluted Average) data on record, last reported at $349.8 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 4.31% year-over-year to $349.8 million; the TTM value through Dec 2025 reached $349.8 million, down 4.31%, while the annual FY2025 figure was $349.8 million, 4.31% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $349.8 million in Q4 2025 per HR's latest filing, roughly flat from $349.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $379.5 million in Q1 2024 and bottomed at $141.6 million in Q3 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $290.9 million, with a median of $349.7 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Diluted Average): tumbled 36.07% in 2021, then soared 154.17% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $142.7 million in 2021, then skyrocketed by 77.89% to $253.9 million in 2022, then soared by 49.26% to $378.9 million in 2023, then decreased by 3.53% to $365.6 million in 2024, then fell by 4.31% to $349.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $349.8 million in Q4 2025, $349.7 million in Q3 2025, and $349.6 million in Q2 2025.